BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012

May 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-05-23

Reporting Person: Jensen Peder (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-23	Automatic Stock Option Grant	$3.32	A	15000	Acquired	2022-05-23	Common Stock (15000)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").

F2: Vest 1/12 per month over 12 months beginning June 23, 2012